Bayesian Framework to Augment Tumor Board Decision Making

Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a consensus on an optimal therapeutic strategy. However, many oncologists lack access to a tumor board, and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasetto, Stefano, Gatenby, Robert A., Enderling, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240793/
https://www.ncbi.nlm.nih.gov/pubmed/33974446
http://dx.doi.org/10.1200/CCI.20.00085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240793/
https://www.ncbi.nlm.nih.gov/pubmed/33974446
http://dx.doi.org/10.1200/CCI.20.00085

Ejemplares similares